ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 067,65
-1,05%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioSig Technologies Inc (BSGM)

  7. BioSig Technologies Inc (BSGM) Actualités

BSGM BioSig Technologies Inc

1,32
0,02 (1,54%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
BioSig Technologies Inc BSGM NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,02 1,54% 1,32 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,31 1,2701 1,39 1,37 1,30
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
04/4/202417:35GLOBEBioSig Engages Consulting Firm for Business Model Strategies
11/3/202414:00EDGAR2Form 8-K - Current report
05/3/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202415:00EDGAR2Form 8-K - Current report
20/2/202416:00GLOBEBioSig Announces Reduction of its Workforce
14/2/202421:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202414:35EDGAR2Form 8-K - Current report
06/2/202414:30GLOBEBioSig’s PURE EP™ Platform with New Near Field Tracking..
02/2/202423:18EDGAR2Form 8-K/A - Current report: [Amend]
01/2/202423:25EDGAR2Form 8-K - Current report
31/1/202422:05EDGAR2Form 8-K - Current report
31/1/202417:15GLOBEBioSig Announces Reverse Stock Split
30/1/202414:52EDGAR2Form 8-K - Current report
30/1/202414:30GLOBEBioSig Announces Cost Reductions to Improve its Financial..
16/1/202422:15EDGAR2Form D - Notice of Exempt Offering of Securities
12/1/202423:28EDGAR2Form 8-K - Current report
08/1/202417:00EDGAR2Form 8-K - Current report
05/1/202422:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
04/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202319:37EDGAR2Form DEL AM - Delaying amendment
28/12/202322:30EDGAR2Form 8-K - Current report
28/12/202322:05EDGAR2Form S-3 - Registration statement under Securities Act of..
22/12/202322:30EDGAR2Form 8-K - Current report
18/12/202322:36EDGAR2Form 8-K - Current report
06/12/202323:07EDGAR2Form 8-K - Current report
06/12/202320:20GLOBEBioSig Issues Letter to Shareholders Detailing Technology..
05/12/202323:29EDGAR2Form 8-K - Current report
05/12/202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:13EDGAR2Form DEF 14A - Other definitive proxy statements
21/11/202323:32EDGAR2Form PRE 14A - Other preliminary proxy statements
14/11/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202323:02EDGAR2Form 8-K - Current report
13/11/202322:30GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
13/11/202314:35EDGAR2Form 8-K - Current report
09/11/202314:00GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
08/11/202322:05EDGAR2Form 8-K - Current report
07/11/202314:01EDGAR2Form 8-K - Current report
07/11/202314:00GLOBEBioSig Appoints Global MedTech Leader Fred Hrkac as New..
03/11/202321:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/11/202321:30EDGAR2Form DEF 14A - Other definitive proxy statements
02/11/202313:00EDGAR2Form 8-K - Current report
02/11/202313:00GLOBEBioSig’s New PURE EP™ Subscription Model Adopted by Mayo..
02/11/202312:17EDGAR2Form 8-K - Current report
01/11/202313:35EDGAR2Form 8-K - Current report
01/11/202313:30GLOBEBioSig Adds Five New Patent Awards to 100+ Total Patent..
24/10/202322:30EDGAR2Form PRE 14A - Other preliminary proxy statements
16/10/202323:00EDGAR2Form 8-K - Current report
27/9/202323:01EDGAR2Form 8-K - Current report
15/9/202322:54EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
BSGM
BioSig Technologies
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés